Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G7FJ
|
||||
| Former ID |
DIB010390
|
||||
| Drug Name |
Meloxicam
|
||||
| Synonyms |
Meloxicam (SoluMatrix/arthritis); Meloxicam nanoformulation capsules (arthritis), iCeutica; Meloxicam (SoluMatrix/arthritis), iCeutica
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
Iroko pharmaceuticals
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C14H13N3O4S2
|
||||
| InChI |
InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)
|
||||
| InChIKey |
ZRVUJXDFFKFLMG-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10369, 855815, 6681236, 7848032, 7979894, 11364527, 11367089, 11369651, 11371577, 11374373, 11377813, 11484638, 11488757, 11490465, 11492602, 11495447, 11528628, 12013466, 14754262, 26612637, 26680359, 26747003, 26747004, 26759123, 29223163, 39290017, 39404337, 42685351, 46506624, 47216906, 47589118, 47589119, 47736629, 48259389, 48413967, 49834840, 50085983, 50100965, 53598948, 53598949, 53598950, 53790511, 56313654, 56320470, 57358017, 81093329, 85087488, 85174237, 87560523, 89736106
|
||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [534421] | |
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| NF-kappa B signaling pathway | |||||
| VEGF signaling pathway | |||||
| TNF signaling pathway | |||||
| Retrograde endocannabinoid signaling | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Oxytocin signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Leishmaniasis | |||||
| Pathways in cancer | |||||
| Chemical carcinogenesis | |||||
| MicroRNAs in cancer | |||||
| Small cell lung cancer | |||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| References | |||||
| Ref 524822 | ClinicalTrials.gov (NCT02183155) Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects. U.S. National Institutes of Health. | ||||
| Ref 542235 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7220). | ||||
| Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.